Simple Summary Metastatic pancreatic ductal adenocarcinoma (mPDAC) has a dismal
prognosis. In selected patients with limited metastatic disease, locoregional therapy, in …

Pancreatic cancer is a challenging malignancy with limited treatment options and poor life
expectancy. The only curative option is surgical resection, but only 15%-20% of patients are …

Background Pancreatic ductal adenocarcinoma (PDAC) remains a malignancy with poor
prognosis, appropriate surgical resection and neoadjuvant therapy depend on the accurate …

Transarterial radioembolization (TARE) with yttrium-90 (Y90) is a promising alternative
strategy to treat liver tumors and liver metastasis from colorectal cancer (CRC), as it …

Simple Summary Sarcomas of the liver are a rare and aggressive group of malignancies for
which surgery is the preferred treatment modality even though most patients are not surgical …

Purpose To assess the safety and effectiveness of transarterial radioembolization (TARE) in
the treatment of hepatic metastases from pancreatic ductal adenocarcinoma (PDAC) …

胰腺癌是一种恶性程度高且预后差的消化系统肿瘤, 肝脏是胰腺癌最常见的转移部位,
发生肝转移者预后更差. 胰腺癌肝转移(PCLM) 手术切除率低, 目前治疗仍以全身静脉化疗为主 …

目的通过建立个体体素模型, 模拟计算胰腺癌治疗中90 Y 玻璃微球给药后对胰腺及周围敏感
器官的吸收剂量, 为90 Y 玻璃微球应用于胰腺癌治疗的临床应用提供技术支撑. 方法在Geant4 …

Radioembolization has become a widespread treatment modality for both primary and
metastatic hepatic malignancies. Although the majority of data and indication for yttrium-90 …

On behalf of The Society of Interventional Oncology, we respectfully request that the NCCN
Pancreatic Adenocarcinoma panel consider including an interventional radiologist (IR) on …